Catalent, Inc. ( CTLT) - Key Metrics
Stock symbol CTLT is outdated, potentially delisted? Maybe it is available on other exchange?
CTLT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $5.62 | -$0.71 | $0.34 | $0.02 |
| 2024Q4 | $7.19 | $0.13 | $1.18 | $0.77 |
| 2024Q3 | $5.90 | -$0.55 | $0.07 | -$0.34 |
| 2024Q2 | $5.63 | -$1.13 | $0.62 | $0.10 |
| 2024Q1 | $5.43 | -$3.95 | -$0.39 | -$0.85 |
CTLT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -21.36 |
| 2024Q4 | ? | 110.49 |
| 2024Q3 | ? | -25.40 |
| 2024Q2 | ? | -9.92 |
| 2024Q1 | ? | -2.88 |
CTLT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q1 | 0.04% | ? |
| 2024Q4 | 1.37% | ? |
| 2024Q3 | -0.60% | ? |
| 2024Q2 | 0.22% | ? |
| 2024Q1 | -1.87% | ? |
CTLT
Price: $63.48
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.28 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 3.0 million
Ebitda: 115.6 millionMarket Capitalization: 11.3 billion